Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

EXAS

Exact Sciences Corp

Dec 26 • 04:00PM ET

57.48

Dollar change -0.63
Percentage change -1.08	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN GH NTRA TXG DGX FLGT BIO QDEL MYGN CSTM

| Held by: VTI VB VXF VBK XBI VHT IWR FBT SCHM IWP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.17	Insider Own	1.45%	Shs Outstand	185.05M	Perf Week	0.17%
Market Cap	10.64B	Forward P/E	-	EPS next Y	-0.25	Insider Trans	0.67%	Shs Float	182.39M	Perf Month	4.24%
Income	-214.04M	PEG	-	EPS next Q	-0.33	Inst Own	99.85%	Short Float	6.14%	Perf Quarter	-15.40%
Sales	2.69B	P/S	3.95	EPS this Y	-6.89%	Inst Trans	3.45%	Short Ratio	4.69	Perf Half Y	29.20%
Book/sh	17.35	P/B	3.31	EPS next Y	78.95%	ROA	-3.25%	Short Interest	11.20M	Perf Year	-24.02%
Cash/sh	5.52	P/C	10.42	EPS next 5Y	-	ROE	-6.76%	52W Range	40.62 - 79.62	Perf YTD	-22.30%
Dividend Est.	-	P/FCF	108.08	EPS past 5Y	4.59%	ROI	-3.75%	52W High	-27.81%	Beta	1.23
Dividend TTM	-	Quick Ratio	1.93	Sales past 5Y	43.88%	Gross Margin	69.46%	52W Low	41.49%	ATR (14)	2.37
Dividend Ex-Date	-	Current Ratio	2.12	EPS Y/Y TTM	25.81%	Oper. Margin	-8.83%	RSI (14)	43.77	Volatility	3.37% 3.69%
Employees	6600	Debt/Eq	0.87	Sales Y/Y TTM	11.91%	Profit Margin	-7.95%	Recom	1.42	Target Price	72.43
Option/Short	Yes / Yes	LT Debt/Eq	0.78	EPS Q/Q	-4911.63%	Payout	-	Rel Volume	0.40	Prev Close	58.11
Sales Surprise	-1.14%	EPS Surprise	-7.20%	Sales Q/Q	12.78%	Earnings	Nov 05 AMC	Avg Volume	2.39M	Price	57.48
SMA20	-5.31%	SMA50	-5.94%	SMA200	-1.25%	Trades		Volume	951,124	Change	-1.08%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-28-24	Initiated	Wells Fargo	Overweight	$75
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$70
Jun-03-24	Resumed	Jefferies	Buy	$75
Jan-02-24	Upgrade	The Benchmark Company	Hold → Buy	$91
Dec-14-23	Initiated	Guggenheim	Buy	$90
Dec-13-23	Initiated	Wolfe Research	Outperform	$95
Oct-10-23	Upgrade	Piper Sandler	Neutral → Overweight	$90
Sep-28-23	Initiated	Bernstein	Outperform	$83
Aug-02-23	Downgrade	The Benchmark Company	Buy → Hold
May-10-23	Upgrade	Craig Hallum	Hold → Buy	$55 → $85
May-05-23	Initiated	UBS	Neutral	$73
Mar-09-23	Upgrade	Citigroup	Neutral → Buy	$70 → $90
Feb-10-23	Downgrade	Credit Suisse	Outperform → Neutral	$50 → $70
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-19-22	Downgrade	Craig Hallum	Buy → Hold	$60 → $35
Aug-25-22	Initiated	Credit Suisse	Outperform	$55
Jun-03-22	Initiated	Piper Sandler	Neutral	$50
Nov-03-21	Downgrade	Raymond James	Strong Buy → Outperform	$160 → $130
Jul-29-21	Reiterated	Stifel	Buy	$165 → $145
Jul-29-21	Reiterated	Oppenheimer	Outperform	$161 → $155

Show Previous Ratings

Nov-26-24 07:27PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) +9.00%
01:24PM	Why Is Exact Sciences Stock Trading Higher On Tuesday? (CORRECTED) (Benzinga)
06:00AM	Exact Sciences to Participate in December Investor Conferences (Business Wire)
Nov-25-24 05:35PM	Exact Sciences Advances Breast Cancer Care with the Oncotype DX test and Genomic Profiling Research at SABCS 2024 (Business Wire)
Nov-19-24 06:57PM	Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey) +8.84%
07:47AM	Loading…
Nov-15-24 07:47AM	Exact Sciences showcases early cancer detection test data at AACR meeting (Clinical Trials Arena)
Nov-13-24 01:00PM	Exact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid Biopsy (Business Wire)
Nov-11-24 09:55AM	Exact Sciences Corporation (EXAS) Rebounded from the Previous Quarter (Insider Monkey)
Nov-08-24 06:46AM	Exact Sciences forecast cut shocks analysts (MedTech Dive)
Nov-07-24 04:05PM	Guardant Health Pops 13% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
10:05AM	Guardant Health Rockets 25% On An 'Impressive' Beat Following Exact Sciences' Flop (Investor's Business Daily)
Nov-06-24 04:04PM	Exact Sciences Collapses On 'Alarming' Guidance Cut. Is The Growth Story Broken? (Investor's Business Daily) -23.48%
11:47AM	Cologuard Maker Exact Sciences Slashes Outlook as Losses Mount (Investopedia)
10:22AM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
10:13AM	Colorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry Point (Benzinga)
06:55AM	Loading…
06:55AM	Q3 2024 Exact Sciences Corp Earnings Call (Thomson Reuters StreetEvents)
02:24AM	Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
12:02AM	Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight (GuruFocus.com)
Nov-05-24 08:42PM	Exact Sciences Stock Falls 29% On Weak Results, Downbeat Outlook (Investor's Business Daily)
07:45PM	Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript (Motley Fool)
05:30PM	Exact Sciences (EXAS) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:29PM	Exact Sciences: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Exact Sciences Announces Third-Quarter 2024 Results (Business Wire)
Nov-01-24 06:00AM	Exact Sciences to Participate in November Investor Conference (Business Wire)
Oct-29-24 12:00PM	Exact Sciences (EXAS) Moves to Strong Buy: Rationale Behind the Upgrade (Zacks)
Oct-27-24 12:00PM	Exact Sciences Presents Multiple Studies at ACG 2024 Demonstrating Leadership in Noninvasive Colorectal Cancer Screening and Patient Engagement (Business Wire)
Oct-17-24 08:00AM	Can This Beaten-Down Cathie Wood Stock Bounce Back? (Motley Fool)
Oct-16-24 10:34AM	Exact Sciences Corporation (EXAS) Bounced Back in Q3 (Insider Monkey)
Oct-09-24 03:36PM	Exact Sciences Corp (EXAS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Oct-08-24 06:00AM	Exact Sciences Schedules Third Quarter 2024 Earnings Call (Business Wire)
03:04PM	Loading…
Oct-07-24 03:04PM	FMR LLC Bolsters Stake in Exact Sciences Corp (GuruFocus.com)
10:33AM	FDA greenlights Exact Sciences newest home colorectal cancer test (Medical Device Network)
06:49AM	Exact Sciences wins FDA approval for Cologuard Plus colorectal cancer test (MedTech Dive)
Oct-05-24 08:35AM	Exact Sciences Corporation (EXAS): A Buzzing AI Health Stock to Add to Your Portfolio (Insider Monkey)
Oct-04-24 09:41AM	FDA Clears Exact Sciences' Next-Generation Colorectal Cancer Diagnostic Test (Benzinga)
09:40AM	Exact Sciences Stock Rises After FDA Signs Off On New Cologuard (Investor's Business Daily)
06:00AM	FDA Approves Exact Sciences' Cologuard Plus Test, Setting a New Benchmark in Non-Invasive Colorectal Cancer Screening (Business Wire)
Sep-18-24 06:03PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
Sep-17-24 07:00AM	The Battle Brewing Over Blood Tests for Cancer (The Wall Street Journal)
Sep-16-24 07:55AM	Exact Sciences says data support its colon cancer blood test (MedTech Dive) +6.01%
07:53AM	ESMO 2024: Exact Sciences unveils results from cancer algorithm trial (Medical Device Network)
02:35AM	Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024 (Business Wire)
Sep-12-24 07:28PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) +5.10%
Sep-11-24 07:18AM	Should You Hold Exact Sciences Corporation (EXAS)? (Insider Monkey) +9.83%
Sep-09-24 09:55AM	Wall Street Analysts Believe Exact Sciences (EXAS) Could Rally 34.33%: Here's is How to Trade (Zacks)
Aug-30-24 11:31AM	Exact Sciences (EXAS) Up 7.5% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-28-24 06:00AM	Exact Sciences to Participate in September Investor Conferences (Business Wire)
Aug-23-24 08:26AM	Should You Believe in the Growth Potential of Exact Sciences Corporation (EXAS)? (Insider Monkey)
06:00AM	Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) (News Direct)
Aug-22-24 09:55AM	Does Exact Sciences (EXAS) Have the Potential to Rally 34.13% as Wall Street Analysts Expect? (Zacks)
09:23AM	Exact Sciences (EXAS) Rides on Cologuard Sales, New Launches (Zacks)
08:41AM	Exact Sciences (EXAS) Enrolls First Patient in Pivotal MCED Study (Zacks)
Aug-21-24 11:08PM	Atlassian Corporation (TEAM): Short Sellers Are Bullish On This Advertising Stock Now (Insider Monkey)
08:08AM	Heres Why Baron Opportunity Fund Sold its Stake in Exact Sciences Corp (EXAS) (Insider Monkey)
07:13AM	Exact Sciences kicks off multi-cancer detection study (Medical Device Network)
Aug-20-24 07:00AM	Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study (Business Wire)
Aug-16-24 07:13AM	Exact Sciences data finds Cologuard detected almost 600k cancer cases (Medical Device Network)
Aug-15-24 07:00AM	New Modeling Data Show the Cologuard Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion (Business Wire)
Aug-14-24 09:19AM	Why You Should Add Exact Sciences (EXAS) to Your Portfolio (Zacks)
Aug-11-24 02:47PM	Atlassian Corporation (TEAM): Hedge Funds Are Bullish on This AdTech Stock Now (Insider Monkey)
Aug-10-24 09:22PM	8 Best AdTech Stocks to Buy Now (Insider Monkey)
Aug-06-24 09:55AM	Wall Street Analysts Predict a 45.04% Upside in Exact Sciences (EXAS): Here's What You Should Know (Zacks)
Aug-02-24 01:08AM	Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight (GuruFocus.com)
Aug-01-24 04:02PM	Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat (Investor's Business Daily) +26.77%
10:49AM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
09:03AM	Exact Sciences (EXAS) Q2 Loss Narrower Than Expected, Sales Beat (Zacks)
12:00AM	Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript (Motley Fool)
Jul-31-24 07:30PM	Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:28PM	Exact Sciences: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology (PR Newswire)
04:05PM	Exact Sciences Announces Second-Quarter 2024 Results (Business Wire)
Jul-24-24 10:01AM	Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-22-24 09:32AM	Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns (InvestorPlace)
Jul-16-24 06:06AM	Lattice Semiconductor Corporation (LSCC) Slipped Due to Cyclical Pressures (Insider Monkey) +5.57%
05:57AM	Exact Sciences Corporation (EXAS) Slipped Over Investors' Concerns (Insider Monkey)
05:53AM	Should You Believe in the Upside Potential of Celsius Holdings (CELH)? (Insider Monkey)
Jul-11-24 06:33AM	Geneoscopys ColoSense deemed reliable in published study (Medical Device Network)
Jul-08-24 08:30AM	This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street (Motley Fool)
06:00AM	Exact Sciences schedules second quarter 2024 earnings call (Business Wire)
Jul-07-24 05:30AM	People Are Feeling Stuck in Their Jobs. Bosses Are Starting to Worry. (The Wall Street Journal)
Jul-03-24 07:00AM	The 3 Best Personalized Medicine Stocks to Buy in July 2024 (InvestorPlace)
Jun-20-24 10:13AM	NGS: the road to personalising cancer care (Medical Device Network)
Jun-17-24 12:54PM	MGI and SeqOne partner to create end-to-end genomic testing platform (Medical Device Network)
Jun-13-24 10:12AM	Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns (InvestorPlace)
06:45AM	Is It Time to Buy May's Worst-Performing Nasdaq Stocks? (Motley Fool)
Jun-07-24 11:30AM	Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report? (Zacks)
Jun-04-24 07:06AM	Illumina names Everett Cunningham as chief commercial officer (MedTech Dive)
Jun-03-24 04:26PM	Is Exact Sciences Corporation (NASDAQ:EXAS) the Gene Therapy Stock with the Greatest Potential? (Insider Monkey)
04:17PM	9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
May-30-24 06:35AM	10 Buzzing AI Semiconductor Stocks in 2024 (Insider Monkey)
May-29-24 11:27AM	Exact Sciences (EXAS) Witnesses Rising Expenses, Competition (Zacks)
May-28-24 10:34AM	Exact Sciences (EXAS) to Showcase Favorable Research Outcome (Zacks) -5.66%
06:00AM	Exact Sciences to Participate in June Investor Conferences (Business Wire)
May-27-24 06:43PM	Hedge Funds are Bullish on This Cancer Stock (Insider Monkey)
06:13PM	7 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
11:34AM	Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns (InvestorPlace)
May-24-24 10:28AM	Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok (The Wall Street Journal) -7.84%
07:11AM	FDA panel backs Guardants blood test for colon cancer (MedTech Dive)
06:05AM	Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO (Business Wire)
May-22-24 07:30AM	Exact Sciences Earns 2024 Great Place To Work Certification (Business Wire)

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Conroy Kevin T	President and CEO	Nov 13 '24	Buy	51.35	19,500	1,001,325	1,074,191	Nov 13 12:56 PM
Baranick Brian	EVP, GM, Precision Oncology	Oct 08 '24	Sale	70.00	929	65,030	12,758	Oct 09 05:00 PM
Baranick Brian	Officer	Oct 08 '24	Proposed Sale	70.00	929	65,030		Oct 08 01:27 PM
Baranick Brian	EVP, GM, Precision Oncology	Sep 18 '24	Sale	70.00	929	65,030	13,687	Sep 19 05:00 PM
Baranick Brian	Officer	Sep 18 '24	Proposed Sale	70.00	929	65,030		Sep 18 04:15 PM
Baranick Brian	EVP, GM, Precision Oncology	Aug 05 '24	Option Exercise	0.00	2,712	0	15,991	Aug 06 05:30 PM
COWARD D SCOTT	Director	May 01 '24	Sale	60.15	67	4,030	44,644	May 02 07:00 PM
Cunningham Everett	Chief Commercial Officer	May 01 '24	Sale	60.15	136	8,180	47,042	May 02 07:00 PM
Herriott James	SVP, General Counsel & Sec	May 01 '24	Sale	60.15	30	1,804	9,866	May 02 07:00 PM
Elliott Jeffrey Thomas	Chief Financial Officer	May 01 '24	Sale	60.15	136	8,180	11,795	May 02 07:00 PM
Baranick Brian	EVP, GM., Precision Oncology	May 01 '24	Sale	60.15	110	6,616	13,279	May 02 07:00 PM
Condella Sarah	EVP, Human Resources	May 01 '24	Sale	60.15	102	6,135	72,611	May 02 07:00 PM
ORVILLE JACOB A	General Manager, Screening	May 01 '24	Sale	60.15	102	6,135	14,440	May 02 07:00 PM
Conroy Kevin T	President and CEO	May 01 '24	Sale	60.15	1,155	69,473	1,156,191	May 02 07:00 PM
Condella Sarah	EVP, Human Resources	Apr 01 '24	Sale	70.00	2,000	140,000	71,787	Apr 03 07:30 PM
Baranick Brian	EVP, GM., Precision Oncology	Apr 02 '24	Sale	79.43	924	73,393	13,171	Apr 03 07:30 PM
Condella Sarah	EVP, Human Resources	Mar 28 '24	Sale	70.00	2,000	140,000	73,787	Apr 01 04:30 PM
ORVILLE JACOB A	General Manager, Screening	Feb 29 '24	Option Exercise	0.00	4,724	0	16,478	Mar 04 08:42 PM
ORVILLE JACOB A	General Manager, Screening	Mar 01 '24	Sale	59.32	2,154	127,775	14,324	Mar 04 08:42 PM
LEVANGIE DANIEL J	Director	Mar 01 '24	Sale	57.50	5,000	287,500	22,975	Mar 04 08:42 PM
Herriott James	General Counsel	Feb 29 '24	Option Exercise	0.00	1,890	0	9,987	Mar 04 08:41 PM
Herriott James	General Counsel	Mar 01 '24	Sale	59.32	862	51,134	9,125	Mar 04 08:41 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 29 '24	Option Exercise	0.00	5,291	0	13,345	Mar 04 08:40 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Mar 01 '24	Sale	59.32	2,412	143,080	10,933	Mar 04 08:40 PM
Doyle James Edward	Director	Mar 01 '24	Sale	57.50	2,000	115,000	50,110	Mar 04 08:39 PM
Cunningham Everett	Chief Commercial Officer	Feb 29 '24	Option Exercise	0.00	5,291	0	48,591	Mar 04 08:38 PM
Cunningham Everett	Chief Commercial Officer	Mar 01 '24	Sale	59.32	2,412	143,080	46,179	Mar 04 08:38 PM
Conroy Kevin T	President and CEO	Feb 29 '24	Option Exercise	0.00	18,143	0	1,307,767	Mar 04 08:38 PM
Conroy Kevin T	President and CEO	Mar 01 '24	Sale	59.32	8,271	490,636	1,299,496	Mar 04 08:38 PM
Condella Sarah	EVP, Human Resources	Feb 29 '24	Option Exercise	0.00	3,779	0	77,511	Mar 04 08:37 PM
Condella Sarah	EVP, Human Resources	Mar 01 '24	Sale	59.32	1,724	102,268	75,787	Mar 04 08:37 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 29 '24	Option Exercise	0.00	4,724	0	16,418	Mar 04 08:36 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Mar 01 '24	Sale	59.32	2,323	137,800	14,095	Mar 04 08:36 PM
ORVILLE JACOB A	General Manager, Screening	Feb 26 '24	Option Exercise	0.00	3,954	0	13,633	Feb 28 07:38 PM
ORVILLE JACOB A	General Manager, Screening	Feb 27 '24	Sale	56.89	1,879	106,896	11,754	Feb 28 07:38 PM
Herriott James	General Counsel	Feb 26 '24	Option Exercise	0.00	1,648	0	8,881	Feb 28 07:38 PM
Herriott James	General Counsel	Feb 27 '24	Sale	56.89	784	44,602	8,097	Feb 28 07:38 PM
Cunningham Everett	Chief Commercial Officer	Feb 26 '24	Option Exercise	0.00	7,678	0	46,948	Feb 28 07:37 PM
Cunningham Everett	Chief Commercial Officer	Feb 27 '24	Sale	56.89	3,648	207,535	43,300	Feb 28 07:37 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 26 '24	Option Exercise	0.00	5,701	0	10,764	Feb 28 07:36 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 27 '24	Sale	56.89	2,710	154,172	8,054	Feb 28 07:36 PM
Conroy Kevin T	President and CEO	Feb 26 '24	Option Exercise	0.00	13,181	0	1,295,887	Feb 28 07:35 PM
Conroy Kevin T	President and CEO	Feb 27 '24	Sale	56.89	6,263	356,302	1,289,624	Feb 28 07:35 PM
Condella Sarah	EVP, Human Resources	Feb 26 '24	Option Exercise	0.00	3,954	0	75,612	Feb 28 07:35 PM
Condella Sarah	EVP, Human Resources	Feb 27 '24	Sale	56.89	1,880	106,953	73,732	Feb 28 07:35 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 26 '24	Option Exercise	0.00	3,954	0	13,721	Feb 28 07:34 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 27 '24	Sale	56.89	2,027	115,316	11,694	Feb 28 07:34 PM
Conroy Kevin T	President and CEO	Feb 23 '24	Option Exercise	13.96	102,837	1,435,605	1,344,266	Feb 26 05:00 PM
Condella Sarah	EVP, Human Resources	Feb 23 '24	Sale	59.72	1,021	60,974	71,658	Feb 26 05:00 PM
ORVILLE JACOB A	General Manager, Screening	Feb 22 '24	Sale	59.78	1,013	60,557	9,679	Feb 23 08:03 PM
Herriott James	General Counsel	Feb 22 '24	Sale	59.78	291	17,396	7,233	Feb 23 08:02 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 22 '24	Sale	59.78	1,351	80,763	5,063	Feb 23 08:01 PM
Cunningham Everett	Chief Commercial Officer	Feb 22 '24	Sale	59.78	1,350	80,703	39,270	Feb 23 08:00 PM
COWARD D SCOTT	Director	Feb 22 '24	Sale	59.78	663	39,634	44,493	Feb 23 07:59 PM
Conroy Kevin T	President and CEO	Feb 22 '24	Sale	59.78	11,565	691,356	1,241,429	Feb 23 07:59 PM
Condella Sarah	EVP, Human Resources	Feb 22 '24	Sale	59.78	1,013	60,557	72,679	Feb 23 07:57 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 22 '24	Sale	59.78	1,093	65,340	9,767	Feb 23 07:57 PM
ORVILLE JACOB A	General Manager, Screening	Feb 20 '24	Option Exercise	0.00	2,248	0	9,736	Feb 22 07:40 PM
ORVILLE JACOB A	General Manager, Screening	Feb 21 '24	Sale	61.50	1,078	66,297	8,658	Feb 22 07:40 PM
Herriott James	General Counsel	Feb 20 '24	Option Exercise	0.00	864	0	7,358	Feb 22 07:39 PM
Herriott James	General Counsel	Feb 21 '24	Sale	61.50	415	25,522	6,943	Feb 22 07:39 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 20 '24	Option Exercise	0.00	3,112	0	5,196	Feb 22 07:38 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 21 '24	Sale	61.50	1,493	91,820	3,703	Feb 22 07:38 PM
COWARD D SCOTT	Director	Feb 20 '24	Option Exercise	0.00	2,248	0	43,828	Feb 22 07:38 PM
COWARD D SCOTT	Director	Feb 21 '24	Sale	61.50	706	43,419	43,122	Feb 22 07:38 PM
Conroy Kevin T	President and CEO	Feb 20 '24	Option Exercise	0.00	10,374	0	1,234,731	Feb 22 07:37 PM
Conroy Kevin T	President and CEO	Feb 21 '24	Sale	61.50	4,975	305,962	1,229,756	Feb 22 07:37 PM
Condella Sarah	EVP, Human Resources	Feb 20 '24	Option Exercise	0.00	2,248	0	72,737	Feb 22 07:36 PM
Condella Sarah	EVP, Human Resources	Feb 21 '24	Sale	61.50	1,079	66,358	71,658	Feb 22 07:36 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 20 '24	Option Exercise	0.00	1,729	0	9,721	Feb 22 07:36 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 21 '24	Sale	61.50	895	55,042	8,826	Feb 22 07:36 PM
ORVILLE JACOB A	General Manager, Screening	Feb 14 '24	Option Exercise	0.00	2,031	0	8,454	Feb 16 06:26 PM
ORVILLE JACOB A	General Manager, Screening	Feb 15 '24	Sale	61.43	966	59,341	7,488	Feb 16 06:26 PM
Herriott James	General Counsel	Feb 14 '24	Option Exercise	0.00	883	0	6,915	Feb 16 06:25 PM
Herriott James	General Counsel	Feb 15 '24	Sale	61.43	421	25,862	6,494	Feb 16 06:25 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 14 '24	Option Exercise	0.00	3,972	0	3,972	Feb 16 06:24 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 15 '24	Sale	61.43	1,888	115,980	2,084	Feb 16 06:24 PM
COWARD D SCOTT	Director	Feb 14 '24	Option Exercise	0.00	3,972	0	42,956	Feb 16 06:23 PM
COWARD D SCOTT	Director	Feb 15 '24	Sale	61.43	1,376	84,528	41,580	Feb 16 06:23 PM
Conroy Kevin T	President and CEO	Feb 14 '24	Option Exercise	0.00	31,133	0	1,239,148	Feb 16 06:22 PM
Conroy Kevin T	President and CEO	Feb 15 '24	Sale	61.43	14,791	908,611	1,224,357	Feb 16 06:22 PM
Condella Sarah	EVP, Human Resources	Feb 14 '24	Option Exercise	0.00	2,031	0	71,454	Feb 16 06:21 PM
Condella Sarah	EVP, Human Resources	Feb 15 '24	Sale	61.43	965	59,280	70,489	Feb 16 06:21 PM
Condella Sarah	EVP, Human Resources	Jan 02 '24	Sale	73.50	2,000	147,000	69,423	Jan 04 05:19 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Jan 02 '24	Sale	73.50	879	64,606	7,992	Jan 04 05:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EXAS

Exact Sciences Corp

Upgrade your FINVIZ experience